Organon (OGN) shares declined 22% in recent Thursday trading after the company reported Q1 adjusted earnings of $1.02 per diluted share, down from $1.22 a year earlier.
Analysts polled by FactSet expected $0.89.
Revenue for the quarter ended March 31 was $1.51 billion, down from $1.62 billion a year earlier.
Four analysts surveyed by FactSet expected $1.51 billion.
The company said it maintained its 2025 revenue outlook of $6.13 billion to $6.33 billion. Analysts surveyed by FactSet expect $6.29 billion.
Price: 9.40, Change: -3.54, Percent Change: -27.34
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。